£Û¹Ø¼ü´Ê£Ý ·¨ÂåËÄÁªÖ¢£¬³ÉÈË£»Íâ¿ÆÊÖÊõ£»ÊÖÊõºó²¢·¢Ö¢
Clinic analysis of total repair of tetralogy of Fallot in 35 adulthood patients
£ÛAbstract£Ý Objective To compare the risk and benefit of total correction of tetralogy of Fallot (TOF) in adulthood.Methods To analyze clinic data and treatment experience in total correction of TOF in adults.Results Operated 35 cases£¬1 death (2.9%)£¬1 residual ventricular septal defect (VSD) (2.9%)£¬1 not complete relief of the right ventricular outflow tract (RVOT) obstruction(2.9%). The mean follow up was 14.3 (1~42) months£¬the cardiac function of 26 patients (76.5%) was NYHA ¢ñ£¬7 patients(20.6%)was NYHA¢ò£¬1 patient(2.9%)was NYHA¢ó(P£¼0.01).Conclusion Total correction of TOF in adulthood patients is safe and effective.
£ÛKey words£Ý tetralogy of Fallot£¬adults;surgical procedures;postoperative complications
³ÉÈË·¨ÂåËÄÁªÖ¢£¨TOF£©ÓÉÓÚ²¡ÈËÐÄÔàºÍÆäËû×éÖ¯³¤ÆÚȱÑõ£¬¿Éµ¼ÖÂÐļ¡Ë𺦡¢ÊÒÐÔÐÄÂÉʧ³£ºÍÐÄË¥£¬ÄýѪ¹¦ÄܺÍÉñ¾¹¦ÄÜÕϰ£¬Òò´ËÄ곤µÄ²¡ÈËÊÇÊÖÊõËÀÍöÂʺͳ¤ÆÚ³É»îÂʵÄΣÏÕÒòËØ£Û1£¬2£Ý£¬ Ŀǰ Íâ¿ÆÊÖÊõÖ¸Õ÷´æÔÚÒ»¶¨µÄÕùÒé¡£ÎÒÔº´Ó1998Äê2ÔÂ~2006Äê3ÔÂÍê³ÉÁË35Àý³ÉÈËTOF¸ùÖÎÊõ£¬ÏÖ ×ܽá ÈçÏ¡£
1 ×ÊÁÏÓë·½·¨
1.1 Ò»°ã×ÊÁÏ 35Àý»¼Õß¾ùÀ´×ÔסԺ²¡ÈË£¬ÆäÖÐÄÐ18Àý£¨51.4£¥£©£¬Å®17Àý£¨48.6£¥£©£¬ÄêÁ䣨20.5¡À3.3£©Ë꣬ÐŦÄÜ¢ñ¼¶10Àý£¨28.6£¥£©£¬¢ò¼¶22Àý£¨62.9£¥£©£¬¢ó¡«¢ô¼¶3Àý£¨8.6£¥£©£¬2Àý»¼ÕßÓÐÊÒÐÔÆÚǰÊÕËõ£¨5.7£¥£©£¬ºÏ²¢¸ÐȾÐÔÐÄÄÚĤÑ×1Àý£¨2.9£¥£©¡£ËùÓл¼Õß¾ùͨ¹ý³¬ÉùÐĶ¯Í¼£¨UCG£©¼°ÐÄѪ¹ÜÔìÓ°È·Á¢Õï¶Ï£¬ÓÒÐÄÊÒµ½·Î¶¯Âöѹ²î£¨88.4¡À26.3£©mmHg£¨54¡«189mmHg£©£¬Æ½¾ù¶¯ÂöѪÑõ±¥ºÍ¶È£¨82.7¡À4.7£©£¥£¨72%¡«94£¥£©£¬ºìϸ°ûѹ»ý£¨49.3¡À12.1£©£¥£¨38%¡«78%£©¡£ºÏ²¢»ûÐΣºÂÑÔ²¿×δ±Õ5Àý£¨14.3£¥£©£¬ÓÒλÖ÷¶¯Âö¹1Àý£¨2.9£¥£©£¬Ö÷¶¯Âö°êÇá¶È¹Ø±Õ²»È«2Àý£¨5.7£¥£©¡£
1.2 ·½·¨ ËùÓл¼Õß²ÉÓ󣹿Âé×íºÍÌåÍâÑ»·¡£È¡ÕýÖÐÇпڣ¬Ö÷¶¯Âö²å¹Ü£¬ÉÏ¡¢ÏÂÇ»¾²Âö²å¹Ü£¬ÖÐ-Éî¶ÈµÍΣ¬Ð£»¤²ÉÓÃÀäÑªÍ£ÌøÒº£¬Ðļ¡Í£ÌøÒº¾Ö÷¶¯Âö¸ù²¿¹à×¢£¬Çпª·¿¼ä¸ôÂÑÔ²ÎÑÖÃ×óÐÄÒýÁ÷¡£
1.2.1 ÓÒ·¿ÇÐ¿Ú Ñ¡ÔñÓÒ·¿ÇпÚ3Àý£¨8.6£¥£©¡£¾ÓÒ·¿ÇпÚÇгý©¶·²¿µÄ·Êºñ±ÚÊøºÍ¸ôÊø£¬ÌرðÊÇÒýÆðÑÏÖØ¹£×èµÄ·Êºñ¼¡ÈâÊø£¬¶ÔÓÚ´óÁ¿ÔöÉúµÄÏËάÄÚĤÓèÒÔС²¿·ÖÇгý¡£ÊÒ¼ä¸ôȱËðÐÞ²¹Ò»°ã²ÉÓõÓÂÚ²¹Æ¬£¬Óùú²úÎÞËðÉË·ìÏß´øµæ¼ä¶Ï·ìºÏÐÞ²¹£¬È·±£ÊÒ¼ä¸ôȱËðÐÞ²¹·ìºÏµÄÑÏÃÜ¡£
1.2.2 ÓÒÊÒÁ÷³öµÀ·Î¶¯ÂöÇÐ¿Ú Ñ¡ÔñÓÒÊÒÁ÷³öµÀ·Î¾²ÂöÇпÚ30Àý£¨85.7£¥£©¡£¾ÓÒ·¿ÇпÚÐÐÊÒ¼ä¸ôȱËðÐÞ²¹ºÍÓÒÊÒÁ÷³öµÀÊèͨºó£¬ÓÃ̽×Ó̽²éÓÒÊÒÁ÷³öµÀ¼°·Î¶¯Âö°ê»·£¬µ±²»ÄÜͨ¹ý20mm̽×Óʱ£¬ÇпªÓÒÊÒÁ÷³öµÀÏòÉÏ¿ç·Î¶¯Âö°ê»·ÖÁ·ÎÖ÷¶¯Âö£¬ÈçÓÒÊÒÁ÷³öµÀÊèͨ²»³©Ôò½øÒ»²½Çгý·ÊºñµÄ¼¡ÈâÊøºÍÔöÉúµÄÏËάÄÚĤ£¬Óзζ¯Âö°ê½»½çÕ³Á¬ÏÁյϼÕßÐн»½çÇпª£¬È¡×ÔÌåÐİüÖÆ×÷´ø°ê²¹Æ¬£¬²¹Æ¬ÉϵÄÈ˹¤°êĤÒàÓÃ×ÔÌåÐİüÖÆ×÷£¬°ê»·Á½¶ËÏÈ·ìºÏ2Õë¹Ì¶¨ÈËÔì°êĤ£¬ÔÙÓÃ4-0 ProleneÏßÁ¬Ðø·ìºÏ£¬¼Ó¿íÓÒÊÒÁ÷³öµÀ¡¢·Î¶¯Âö°ê»·¼°·Î¶¯Âö£¬ÒÔÄÜͨ¹ý20mm̽×ÓΪ׼¡£ºÏ²¢¸ÐȾÐÔÐÄÄÚĤÑ׵ϼÕߣ¬Çå³ý׸ÉúÎ0.25£¥µâ·üÏû¶¾ºóÉúÀíÑÎË®ÇåÏ´£¬¾¡¿ÉÄܱ£»¤ºÃ°êĤ¡£
2 ½á¹û
ÊõºóÔçÆÚËÀÍö1Àý£¨ÊõºóµÚ3Ì죩£¬ËÀÍöÔÒòΪÍç¹ÌµÄµÍÐÄÅÅ¡£1Àý»¼ÕßÊõºó7ÌìUCG¸´²é·¢ÏÖÊÒȱ²ÐÓà©£¬Ö±¾¶Ô¼0.3cm£¬Î´ÔÙ´ÎÊÖÊõ£¬ÎÞÔٴοªÐØÖ¹Ñª²¡ÈË¡£ÔÚICUƽ¾ù4.3Ì죬סԺ10.7Ìì¡£33Àý²¡È˻ָ´Á¼ºÃ£¬ÎÞ¶ñÐÔÐÄÂÉʧ³£¡¢Éñ¾ÏµÍ³²¢·¢Ö¢µÈ¡£ÖеÈÁ¿ÒÔÉÏÐİü»ýÒº3Àý£¨1ÀýΪÓÒ·¿Çпڣ¬2ÀýΪÓÒÊÒÁ÷³öµÀ·Î¶¯ÂöÇпڣ©£¬¾´©´Ì³éÒººó2ÀýÏûʧ£¬1Àý¸ÄÉÆ¡£Æ½¾ùËæ·Ã14.3£¨1~42£©¸öÔ£¬´æ»î34Àý£¬½üÆÚËæ·Ã34Àý²¡ÈËÖÐÐŦÄÜNYHA¢ñ¼¶26Àý£¨74.3%£©£¬ÐŦÄÜ¢ò¼¶7Àý£¨20.6£¥£©£¬ÐŦÄÜ¢ó¼¶1Àý£¨2.9£¥£©£¬Êõºó»¼ÕßÐŦÄܽÏÊõǰ²îÒìÓзdz£ÏÔÖøÐÔ£¨P£¼0.01)¡£UCG¸´²éÊõºóÓÐ1Àý»¼ÕßÓÒÊÒµ½·Î¶¯ÂöµÄѹ²îΪ76mmHg£¨2.9£¥£©£¬12Àý£¨34.3£¥£©»¼Õ߷ζ¯Âö°êÇá¶È·µÁ÷£¬20Àý£¨57.1£¥£©Çáµ½ÖжȷµÁ÷£¬2Àý£¨5.7£¥£©ÖжÈÒÔÉÏ·µÁ÷¡£4Àý»¼Õߣ¨11.4£¥£©¿ÉÄÜÓÐÐÄÂÉʧ³£¡£
3 ÌÖÂÛ
Ä곤µÄTOFÊÇÊÖÊõËÀÍöÂʺͳ¤ÆÚ´æ»îÂʵķçÏÕÒòËØ£Û3£Ý£¬ ÎÄÏ× ±¨µÀÊÖÊõµÄËÀÍöÂÊΪ2.5%¡«16%£Û3£Ý£¬Óë±¾×éËÀÍöÂÊ£¨2.9%£©Ïà½ü¡£Nollert£Û4£ÝµÈ±¨µÀÁËÊõºó´æ»î35ÄêµÄ²¡Àý£¬Rammohan£Û5£ÝÒ²±¨µÀÁËÊõºóÐŦÄÜÏÔÖø¸ÄÉÆºÍÊÙÃüµÄÑÓ³¤Ã÷ÏÔÓÅÓÚ½öÓÃÒ©ÎïÖÎÁÆÕß¡£±¾ÎĵĽá¹ûҲ֤ʵÁËÊÖÊõ¿ÉÃ÷ÏÔ¸ÄÉÆÐŦÄÜ£¬Ìá¸ß»¼ÕßµÄÉú»îÖÊÁ¿¡£